Also, BCP-ALL can be classified as pro-B, common or pre-B ALL based on the expression of markers such as CD19, CD10 and intracellular IGHM, TdT (DNTT) and Igα (CD79A) determined by flow cytometry [35]. Here, CD79A is linked to acute lymphoblastic leukemia.